CALS scientists are furthering the success and legacy of the Wisconsin Alumni Research Foundation 100 years after its founding.
Hector DeLuca left his mark on the UW–Madison campus — literally. The professor emerit and former chair of biochemistry has three buildings that bear his name, recognition of his many research and teaching contributions. His work on vitamin D led to chemical synthesis of vitamin analogs that have been used to treat diseases such as kidney failure, rickets, and osteoporosis. He is listed as an inventor on almost 2,000 patents and founded three biotechnology companies, including Tetrionics, a pharmaceutical ingredients manufacturer acquired by the chemical company Sigma-Aldrich in 2004.